Modified allogeneic MSC_apceth_111

N/A

Report date: 2024/07/30 17:49:25

Base Information

Drug NameModified allogeneic MSC_apceth_111

Drug Alias NameAgenmestencel-L

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsGastrointestinal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesApceth Gmbh & Co Kg

China Registration ClassN/A

Develop Information

Active CompaniesApceth Gmbh & Co Kg

Inactive CompaniesN/A

Active IndicationsGastrointestinal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A